MEDNAX (MD) Misses Q2 EPS by 1c

MEDNAX (NYSE: MD) reported Q2 EPS of $0.47, $0.01 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $486 million versus the consensus estimate of $493.67 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Five Below (FIVE) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY27 Guidance
• Pediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in Neonatology